CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Ali Faraz Chief Executive Officer | Grant or award | +122,000 | 539,782 | ||
| 2026-09-10 | Ali Faraz Chief Executive Officer | Grant or award · Stock Option (Right to buy) | +732,500 | 732,500 | ||
| 2026-09-10 | Tingley Whittemore Chief Medical Officer | Grant or award | +49,000 | 263,073 | ||
| 2026-09-10 | Tingley Whittemore Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +293,000 | 293,000 | ||
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −5,837 | $0.71 | $4K | 434,177 |
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −3,969 | $0.71 | $3K | 430,208 |
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −5,020 | $0.71 | $4K | 425,188 |
| 2026-08-17 | Ali Faraz Chief Executive Officer | Sale | −7,406 | $0.71 | $5K | 417,782 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −1,637 | $0.71 | $1K | 219,860 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −1,637 | $0.71 | $1K | 218,223 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −1,871 | $0.71 | $1K | 216,352 |
| 2026-08-17 | Tingley Whittemore Chief Medical Officer | Sale | −2,279 | $0.71 | $2K | 214,073 |
| 2026-07-13 | Hyllengren Eric J Chief Financial Officer | Grant or award · Stock Option (Right to buy) | +1,650,000 | 1,650,000 | ||
| 2026-05-28 | Williams R Sanders Director | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2026-05-28 | Walsh Jeffrey T. Director | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2026-05-28 | Stehman-Breen Catherine Director | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2026-05-28 | Srivastava Deepak Director | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2026-05-28 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2026-05-28 | Lee June Director | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2026-05-28 | Burroughs Amy L. Director | Grant or award · Stock Option (Right to buy) | +120,000 | 120,000 |
Page 1 of 12 · 228 trades